Jesse  Neri net worth and biography

Jesse Neri Biography and Net Worth

Jesse Neri is Senior Vice President, Chief Financial Officer at Rockwell Medical. With nearly 25 years' experience leading finance functions at both public and private companies, Mr. Neri joined Rockwell Medical in October 2023 as SVP, Finance to oversee all aspects of the Company's finance organization. Prior to joining Rockwell Medical, Mr. Neri was the Executive Director of Finance at Hemavant Sciences and Aruvant Sciences, clinical-stage biopharmaceutical companies that are members of the Roivant portfolio that develop therapeutics to improve the lives of patients with blood disorders and hematological malignancies. Previously, Mr. Neri served as Senior Vice President of Finance at Zyla Life Sciences, a public pharmaceutical company with annual revenue of $80 million. As a member of the senior management team, Mr. Neri was responsible for all aspects of its finance organization including SEC reporting, audit, controllership, and strategic planning. While at Zyla, he played a pivotal role in multiple product acquisitions, financings, commercial product launches and regulatory approvals, along with Zyla's acquisition by Assertio Therapeutics in May 2020. Prior to Zyla, Mr. Neri served as Vice President of Financial Planning and Analysis at Symphony Health Solutions, a private equity-backed market research company with revenue of over $200 million. Mr. Neri received a B.S. in Business Administration of Finance from Villanova University and an M.B.A. from Drexel University LeBow School of Business.

What is Jesse Neri's net worth?

The estimated net worth of Jesse Neri is at least $106.92 thousand as of July 1st, 2025. Neri owns 12,661 shares of Rockwell Medical stock worth more than $106,922 as of September 28th. This net worth approximation does not reflect any other investments that Neri may own. Learn More about Jesse Neri's net worth.

How do I contact Jesse Neri?

The corporate mailing address for Neri and other Rockwell Medical executives is 30142 Wixom Road, Wixom, MI, 48393. Rockwell Medical can also be reached via phone at (800) 449-3353 and via email at [email protected]. Learn More on Jesse Neri's contact information.

Has Jesse Neri been buying or selling shares of Rockwell Medical?

Jesse Neri has not been actively trading shares of Rockwell Medical during the last ninety days. Most recently, Jesse Neri sold 88 shares of the business's stock in a transaction on Tuesday, July 1st. The shares were sold at an average price of $8.20, for a transaction totalling $721.60. Following the completion of the sale, the chief financial officer now directly owns 12,661 shares of the company's stock, valued at $103,820.20. Learn More on Jesse Neri's trading history.

Who are Rockwell Medical's active insiders?

Rockwell Medical's insider roster includes John Cooper (Director), Heather Hunter (COO), and Jesse Neri (CFO). Learn More on Rockwell Medical's active insiders.

Are insiders buying or selling shares of Rockwell Medical?

During the last year, insiders at the sold shares 2 times. They sold a total of 793 shares worth more than $7,814.30. The most recent insider tranaction occured on November, 18th when Director John G Cooper sold 507 shares worth more than $4,410.90. Insiders at Rockwell Medical own 4.6% of the company. Learn More about insider trades at Rockwell Medical.

Information on this page was last updated on 11/18/2025.

Jesse Neri Insider Trading History at Rockwell Medical

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/1/2025Sell88$8.20$721.6012,661View SEC Filing Icon  
4/1/2025Sell88$11.00$968.003,000View SEC Filing Icon  
See Full Table

Jesse Neri Buying and Selling Activity at Rockwell Medical

This chart shows Jesse Neri's buying and selling at Rockwell Medical by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Rockwell Medical Company Overview

Rockwell Medical logo
Rockwell Medical, Inc., together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. The company offers Triferic Dialysate and Triferic AVNU which are indicated to maintain hemoglobin in adult undergoing hemodialysis. It also manufactures, sells, delivers, and distributes hemodialysis concentrates, such as CitraPure citric acid concentrate, Dri-Sate dry acid concentrate, RenalPure liquid acid concentrate, dry acid concentrate mixer, and RenalPure and SteriLyte powder bicarbonate concentrate; and ancillary products, including testing supplies, 5% acetic acid cleaning solution, 5% and 2% citric acid descaler, filtration salts, and other items used by hemodialysis providers. The company's hemodialysis concentrate products are used to sustain patient's life by removing toxins and balancing electrolytes in a dialysis patient's bloodstream. The company serves to hemodialysis clinics. Rockwell Medical, Inc. was incorporated in 1996 and is headquartered in Wixom, Michigan.
Read More

Today's Range

Now: $8.45
Low: $8.26
High: $8.50

50 Day Range

MA: $7.62
Low: $6.28
High: $8.85

2 Week Range

Now: $8.45
Low: $4.89
High: $12.90

Volume

3,861 shs

Average Volume

43,455 shs

Market Capitalization

$34.03 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.64